article thumbnail

Adjunctive Methylene Blue in Septic Shock?

RebelEM

septic shock). Most of the research on the use of MB has been in patients with vasoplegia following cardiopulmonary bypass. Limited, small studies on its use in septic shock do not make a clear argument for use. Early Adjunctive Methylene Blue in Patients with Septic Shock: A Randomized Controlled Trial. Crit Care 2023.

Shock 145
article thumbnail

The ECLS-SHOCK Trial: ECPR in Infarct-Related Cardiogenic Shock

RebelEM

Background: Cardiogenic shock develops in up to 10% of patients with acute myocardial infarction (AMI) and carries a 30 day mortality rate around 50%. Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. Many centers have attempted ECLS to achieve hemodynamic stabilization in this group of patients. Control: 53.4%

Shock 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Research Roundup (July 2024)

First 10 EM

BiPAP for […] The post Research Roundup (July 2024) appeared first on First10EM. (I tend to read ridiculous articles in my free time, which I have had very little of, and so there are no intubation in outer space or highly philosophical papers about the language this month. Don’t worry, there is still a very bad joke.)

article thumbnail

Diastolic Shock Index: A clinically relevant predictor of poor outcome in septic shock?

Taming the SRU

Diastolic shock index and clinical outcomes in patients with septic shock. O: There was an association between increased diastolic shock index score and mortality at 90 days and performed similarly to more advanced measures of morbidity and mortality in septic shock including lactate levels and SOFA scores.

Shock 52
article thumbnail

Adrenaline nasal spray: the revolution against allergic shock

Emergency Live

FDA approved the first adrenaline-based nasal spray used to treat anaphylactic shock An epochal breakthrough in the management of severe allergic reactions has been announced by the US Food and Drug Administration (FDA).

Shock 52
article thumbnail

Patel – High-Dose B12 in Septic Shock

University of Maryland CC Project

His particularly research […] Dr. Jayshil Patel is an associate professor at the Medical College of Wisconsin and a board certified physician in internal medicine, pulmonary medicine, and critical care medicine.

Shock 40
article thumbnail

Is the blind Subclavian “trauma line” a thing of the past?

Greater Sydney Area HEMS

Obtaining access in shocked trauma patients can be notoriously difficult due to circulatory collapse. Those who are shocked, shut down with limited or no other options for peripheral access require central access. It is currently the subject of future research and publication in the emergency department setting. Green et al.